Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Active as of 2024-04-27 |
Generated Narrative: EvidenceVariable
Resource EvidenceVariable "179689" Version "4" Updated "2023-12-04 15:43:55+0000"
Profile: GroupAssignment
EvidenceVariableDefinition: Defined in handling and category elements (Evidence Based Medicine on FHIR Implementation Guide Code System#defined-in-handling-and-category)
url: https://fevir.net/resources/EvidenceVariable/179689
identifier: FEvIR Object Identifier/179689
version: 1.0.0-ballot
name: GroupAssignment_high_dose_xanomeline_vs_low_dose_xanomeline_vs_placebo
title: GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo
status: active
date: 2024-04-27 20:42:39+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description: This example of a GroupAssignment Profile describes a 3-arm trial (so handling='polychotomous') and lists the 3 trial arms in category.name elements. Because the definition of this EvidenceVariable Resource is fully expressed in the handling and category elements, the defintion.concept element uses a CodeableConcept for 'Defined in handling and category elements'.
Code | Value[x] |
Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication') | GroupAssignment (Evidence Based Medicine on FHIR Implementation Guide Code System#GroupAssignment) |
copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/
author: Brian S. Alper:
Type | Citation |
cite-as | GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179689. Revised 2023-12-01. Available at: https://fevir.net/resources/EvidenceVariable/179689. Computable resource at: https://fevir.net/resources/EvidenceVariable/179689. |
handling: polychotomous
category
name: high dose xanomeline
category
name: low dose xanomeline
category
name: placebo